⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6618896 | 1.00 | — | — | |
| SCHEMBL2920884 | 1.00 | — | — | |
| SCHEMBL13857686 | 0.84 | ALDH1A1 (0.32) | — | |
| SCHEMBL15109505 | 0.78 | — | — | |
| SCHEMBL11273625 | 0.78 | — | — | |
| SCHEMBL2407423 | 0.78 | — | — | |
| SCHEMBL3316118 | 0.78 | — | — | |
| SCHEMBL1643939 | 0.78 | — | — | |
| SCHEMBL17849546 | 0.76 | ALDH1A1 (0.39) | — | |
| SCHEMBL164682 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3465213-A1 | METABALOMICS AND VIRAL DIAGNOSTICS SUITE | Excision Biotherapeutics, Inc. (US) | 2019-04-10 | — | — | EP | claimed |
| WO-2017205460-A1 | METABALOMICS AND VIRAL DIAGNOSTICS SUITE | EXCISION BIOTHERAPEUTICS, INC. (US) | 2017-11-30 | — | — | WO | claimed |
| EP-1546150-B1 | PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES | AMURA THERAPEUTICS LTD (GB) | 2009-03-04 | — | — | EP | claimed |
| US-20070129383-A1 | Substituted 2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivative and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2007-06-07 | — | — | US | claimed |
| EP-1674454-A1 | SUBSTITUTED 2-AMINO- 1,2,4 TRIAZOLO 1,5-a PYRIMIDINE DERIVATIVE AND USE THEREOF | Nippon Kayaku Kabushiki Kaisha (JP) | 2006-06-28 | — | — | EP | claimed |
| US-20060100431-A1 | Biologically active compounds | AMURA THERAPEUTICS LIMITED (GB) | 2006-05-11 | — | — | US | claimed |
| EP-1546150-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | Amura Therapeutics Limited (GB) | 2005-06-29 | — | — | EP | claimed |
| WO-2004007501-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | AMURA THERAPEUTICS LIMITED (GB) | 2004-01-22 | — | — | WO | claimed |
| EP-0976760-B1 | Oligopeptides with fungicidal activity | ISAGRO SPA (IT) | 2002-12-18 | — | — | EP | claimed |
| US-6084065-A | FOR AGRICULTURAL USE | ISAGRO SPA (IT) | 2000-07-04 | — | — | US | claimed |
| EP-0652229-B1 | Oligopeptides with fungicidal activity | ISAGRO SPA (IT) | 2000-05-24 | — | — | EP | claimed |
| EP-0976760-A2 | Oligopeptides with fungicidal activity | ISAGRO S.p.A. (IT) | 2000-02-02 | — | — | EP | claimed |
| EP-0652229-A2 | Oligopeptides with fungicidal activity | ISAGRO S.p.A. (IT) | 1995-05-10 | — | — | EP | claimed |
| EP-4181781-B1 | BREATH-BASED THERAPEUTIC DRUG MONITORING METHOD | UNIV KINDERSPITAL BEIDER BASEL (CH) | 2026-05-20 | — | — | EP | disclosed |
| EP-3478278-B1 | METHOD OF DETERMINING ACUTE OR NON-HEALING WOUNDS | AGENCY SCIENCE TECH & RES (SG) | 2024-06-12 | — | — | EP | disclosed |
| WO-2024010854-A1 | RAPID GENERATION OF BREATH-BASED HEALTH REPORTS AND SYSTEMS FOR USE IN THE SAME | DIAGNOSE EARLY, INC. (US) | 2024-01-11 | — | — | WO | disclosed |
| US-5225402-A | Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-06 | — | — | US | disclosed |
| US-4914206-A | ANTIBIOTICS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-04-03 | — | — | US | disclosed |
| EP-0226896-A2 | Lankacidin derivatives and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1987-07-01 | — | — | EP | disclosed |
| US-4062947-A | Di-N-alkylaminoglycosides, methods for their manufacture and novel intermediates useful therein, method for their use as antibacterial agents and pharmaceutical compositions useful therefor | SCHERING CORPORATION (US) | 1977-12-13 | — | — | US | disclosed |